Short answer
Becton Dickinson (BDX) filed an 8-K current report with the SEC on July 22, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure). Michael D. Garrison retiring from executive vice president and segment president role.
Becton Dickinson 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Michael D. Garrison retiring from executive vice president and segment president role
- Departure effective after fiscal year-end, providing transition continuity
- Search underway for next Medical Essentials segment president
- BioPharma Systems to report directly to CEO Thomas E. Polen
- Reporting change streamlines operating structure but increases CEO oversight requirements
Item 7.01 · Regulation FD Disclosure
- No substantive Item 7.01 disclosure provided
- Filing signed by Stephanie M. Kelly, Chief Securities and Governance Counsel and Corporate Secretary
- Signature dated July 22, 2026
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Becton Dickinson 8-K filings
Get the next BDX 8-K as it lands
Follow BDX for push alerts, or ask the research agent what this filing means.